Mohammed Najeeb Al Hallak

Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma

Asfar S. Azmi, Husain Yar Khan, Irfana Muqbil et al. · Clinical Cancer Research · 2019 · 57 citations · Full text

Medicine, Oncology, Pharmacology +15

Gastric Cancer Heterogeneity and Clinical Outcomes

Rachel Sexton, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin et al. · Technology in Cancer Research & Treatment · 2020 · 51 citations · Full text

Medicine, Molecular Biology, Oncology +17

The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring <i>NRG1</i> gene fusions

Dong‐Wan Kim, Alison M. Schram, Antoine Hollebecque et al. · Future Oncology · 2024 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth

Husain Yar Khan, Gabriel Mpilla, Rachel Sexton et al. · Cancers · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers

Husain Yar Khan, Misako Nagasaka, Yiwei Li et al. · Cancer Research Communications · 2022 · 27 citations · Full text

Medicine, Oncology, Pharmacology +14